RhumbLine Advisers’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $14.9M | Sell |
|
|||||
|
2023
Q3 | $8.03M | Buy |
|
|||||
|
2023
Q2 | $10.2M | Buy |
|
|||||
|
2023
Q1 | $7.99M | Buy |
|
|||||
|
2022
Q4 | $8.26M | Buy |
|
|||||
|
2022
Q3 | $9.02M | Buy |
|
|||||
|
2022
Q2 | $3.93M | Buy |
|
|||||
|
2022
Q1 | $2.93M | Buy |
|
|||||
|
2021
Q4 | $2.94M | Sell |
|
|||||
|
2021
Q3 | $2.77M | Buy |
|
|||||
|
2021
Q2 | $2.52M | Buy |
|
|||||
|
2021
Q1 | $2.21M | Sell |
|
|||||
|
2020
Q4 | $2.03M | Buy |
|
|||||
|
2020
Q3 | $1.53M | Sell |
|
|||||
|
2020
Q2 | $2.54M | Buy |
|
|||||
|
2020
Q1 | $1M | Buy |
|
|||||
|
2019
Q4 | $378K | Buy |
|